Emerging research points to shared mechanisms among IBS, obesity, T2D, and cancer, with chronic inflammation as a unifying theme: IBS involves mucosal immune activation, while obesity and T2D are marked by elevated cytokines such as TNF-α and IL-6 [14,15,16]. This evidence concerns the gene IL6 and irritable bowel syndrome.